Compare MORN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MORN | TECH |
|---|---|---|
| Founded | 1984 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.2B |
| IPO Year | 2005 | 1989 |
| Metric | MORN | TECH |
|---|---|---|
| Price | $204.65 | $65.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $322.50 | $70.46 |
| AVG Volume (30 Days) | 383.4K | ★ 2.1M |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.98% | 0.47% |
| EPS Growth | ★ 16.18 | N/A |
| EPS | ★ 8.80 | 0.49 |
| Revenue | ★ $2,395,400,000.00 | $1,216,732,000.00 |
| Revenue This Year | $8.92 | $2.33 |
| Revenue Next Year | $7.55 | $6.89 |
| P/E Ratio | ★ $23.10 | $140.18 |
| Revenue Growth | ★ 7.76 | 3.85 |
| 52 Week Low | $199.97 | $46.01 |
| 52 Week High | $335.21 | $79.28 |
| Indicator | MORN | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 40.64 | 50.90 |
| Support Level | $199.97 | $66.94 |
| Resistance Level | $214.74 | $68.54 |
| Average True Range (ATR) | 6.74 | 2.45 |
| MACD | -1.08 | -0.22 |
| Stochastic Oscillator | 24.61 | 26.11 |
Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.